Circ_0020123 enhances the cisplatin resistance in non-small cell lung cancer cells partly by sponging miR-140-3p to regulate homeobox B5 (HOXB5)

Cisplatin (DDP) therapy is widely used for the treatment of non-small cell lung cancer (NSCLC), but the curative effect is limited by chemoresistance. This study was designed to explore circ_0020123 function in DDP resistance of NSCLCDDP. Expression detection for circ_0020123, microRNA-140-3p (miR-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Dong, Zeng, Jing, Rong, Feng, Xu, Yasheng, Wei, Rong, Zou, Can
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974048/
https://www.ncbi.nlm.nih.gov/pubmed/35170372
http://dx.doi.org/10.1080/21655979.2022.2036910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974048/
https://www.ncbi.nlm.nih.gov/pubmed/35170372
http://dx.doi.org/10.1080/21655979.2022.2036910

Ejemplares similares